Tpharm.info


Zolpidem tartrate er 12.5 mg tablets





Ambien CR (Zolpidem Tartrate) Drug Information Indications

5/12/2014
05:58 | Author: David Perry

Zolpidem tartrate er 12.5 mg tablets
Ambien CR (Zolpidem Tartrate) Drug Information Indications

Ambien CR (zolpidem tartrate extended-release tablets) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep.

AMBIEN CR is available as extended-release tablets containing 6.25 mg or 12.5 mg of zolpidem tartrate for oral administration.

Comments (1)Read more



DailyMed - AMBIEN CR- zolpidem tartrate tablet, coated

11/21/2014
03:24 | Author: Emma Coleman

Zolpidem tartrate er 12.5 mg tablets
DailyMed - AMBIEN CR- zolpidem tartrate tablet, coated

NDC Code(s): , , ; Packager: Rebel Distributors Corp. This is a repackaged label. Source NDC Code(s):.

Although studies did not reveal respiratory depressant effects at hypnotic doses of zolpidem in normals or in patients with mild to moderate chronic obstructive pulmonary disease (COPD), a reduction in the Total Arousal Index together with a reduction in lowest oxygen saturation and increase in the times of oxygen desaturation below 80% and 90% was observed in patients with mild-to-moderate sleep apnea when treated with an immediate-release formulation of zolpidem tartrate (10 mg) when compared to placebo.

Comments (2)Read more

Ambien CR (zolpidem tartrate extended-release) CIV Tablets

11/20/2014
01:14 | Author: Lauren Ross

Zolpidem tartrate er 12.5 mg tablets
Ambien CR (zolpidem tartrate extended-release) CIV Tablets

Ambien CR(R) 12.5 mg significantly improved sleep onset, sleep maintenance and total sleep time compared to placebo Sanofi-aventis.

Select any link below to view the RSS feed.

We comply with the HONcode standard for trustworthy health information. Verify here.

Ambien CR is indicated for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).

Comments (3)Read more